TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Cooper Co ( (COO) ).
On December 4, 2025, CooperCompanies announced that Robert S. Weiss resigned as Chairman of the Board, effective January 2, 2026, with Colleen E. Jay appointed as his successor. The company also reported its financial results for the fiscal fourth quarter and full year ending October 31, 2025, showing a 5% increase in revenue to $4.1 billion and a 12% rise in non-GAAP EPS to $4.13, despite a 4% decline in GAAP EPS. The company aims to drive long-term shareholder value through growth, profitability, and strategic investments.
The most recent analyst rating on (COO) stock is a Buy with a $88.00 price target. To see the full list of analyst forecasts on Cooper Co stock, see the COO Stock Forecast page.
Spark’s Take on COO Stock
According to Spark, TipRanks’ AI Analyst, COO is a Outperform.
Cooper Co’s strong financial performance and bullish technical indicators are the primary drivers of its stock score. While the company shows robust growth and profitability, valuation concerns and revenue challenges highlighted in the earnings call temper the overall score.
To see Spark’s full report on COO stock, click here.
More about Cooper Co
CooperCompanies is a leading global medical device company, primarily focused on vision care and surgical products. The company operates through two business units: CooperVision, which specializes in contact lenses, and CooperSurgical, which offers a range of products and services for women’s health, fertility, and diagnostics.
Average Trading Volume: 2,680,538
Technical Sentiment Signal: Sell
Current Market Cap: $15.08B
Find detailed analytics on COO stock on TipRanks’ Stock Analysis page.